secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2026-06-18T20:28:44+00:00
Accession:  0001650664-26-000063
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine holds 2026 annual meeting; elects two Class I directors and ratifies auditor
--------------------------------------------------------------------------------

- Stockholders elected Bernadette Connaughton (28.66M for, 10.79M withheld) and Elliott Levy, M.D. (37.10M for, 2.35M withheld) as Class I directors.
- Non-binding advisory vote on named executive officer compensation passed with 32.91M for, 6.32M against, 0.21M abstain.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2026 approved with 64.69M for, 0.77M against, 0.39M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/0001650664-26-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/edit-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001650664-26-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer